Company Overview
Spectral Molecular Imaging, Inc. develops biomedical optical imaging devices for better, earlier detection of major disease, such as cancer. It uses a combination of photonic imaging methods to better understand and characterize live human tissue, non-invasively and quantitatively. This multimode approach has proven its value in a number of clinical applications, starting with melanoma detection. Results have been published and yielded regulatory clearance.